Tenofovir, Emtricitabine and Efavirenz Tablets are a critical antiretroviral combination widely used in HIV treatment. The global demand for this formulation is increasing as healthcare providers seek consistent, high-quality medicines for patients. Kureasia Pharma offers reliable bulk, contract, and 3rd party manufacturing services, ensuring compliance with international standards and timely delivery for global markets.
Our WHO-GMP certified facilities produce Tenofovir, Emtricitabine and Efavirenz Tablets with stringent quality controls, validated formulations, and precise batch testing. We supply to hospitals, pharmaceutical distributors, tender suppliers, and healthcare organizations across Nigeria, Iraq, Africa, and the Middle East, making us a trusted partner for global pharmaceutical procurement.
Why Choose Kureasia Pharma for Tenofovir, Emtricitabine and Efavirenz Tablets?
Kureasia Pharma is committed to quality, consistency, and regulatory compliance. Every batch of Tenofovir, Emtricitabine and Efavirenz Tablets is manufactured under controlled conditions with detailed quality assurance checks.
Our Advantages Include:
WHO-GMP certified manufacturing units
Advanced quality control and testing
Precision in tablet formulation and potency
Timely global dispatch and export support
Bulk, contract, and 3rd party manufacturing options
Compliance with international export regulations
Our focus is on reliable production and global supply, helping partners secure uninterrupted access to this essential medication.
Comprehensive Manufacturing Services
Kureasia Pharma offers a range of services for Tenofovir, Emtricitabine and Efavirenz Tablets, designed to meet the needs of international buyers.
1. Bulk Manufacturing
We offer large-scale production with strict quality checks, ensuring uniform potency, dissolution, and stability for each batch.
2. Contract Manufacturing
Our contract manufacturing services allow clients to produce Tenofovir, Emtricitabine and Efavirenz Tablets under a structured, long-term agreement, maintaining regulatory compliance and timely production.
3. 3rd Party Manufacturing
We provide end-to-end 3rd party manufacturing, from formulation to packaging, without compromising quality or compliance, ideal for companies looking to outsource production.
4. Export-Ready Supply
Kureasia Pharma ensures smooth export of Tenofovir, Emtricitabine and Efavirenz Tablets to Nigeria, Iraq, Africa, and the Middle East. Our team handles documentation, regulatory clearance, packaging compliance, and freight logistics.
Therapeutic Benefits of Tenofovir, Emtricitabine and Efavirenz Tablets
This combination is highly effective in suppressing HIV viral load, reducing transmission risk, and improving patients’ quality of life.
Key Advantages:
Potent antiviral action against HIV-1
Supports once-daily dosing for better compliance
Suitable for long-term HIV management
Formulated with precision to meet pharmacopoeial standards
Stable and safe for global distribution
Kureasia Pharma has extensive experience in international pharmaceutical exports, ensuring clients in Nigeria, Iraq, Africa, and the Middle East receive consistent and compliant supply.
Export Benefits:
COA, MOA, MSDS, and stability reports included
Proper packaging and labeling for customs compliance
Efficient logistics and freight management
Timely and reliable delivery
Our export solutions help buyers avoid regulatory hurdles and ensure a smooth supply chain.
Why Global Buyers Trust Kureasia Pharma
Consistent supply of high-quality Tenofovir, Emtricitabine and Efavirenz Tablets
Professional manufacturing with WHO-GMP certification
Advanced quality testing and documentation
Transparent operations for long-term partnerships
Expertise in bulk, contract, and 3rd party pharmaceutical manufacturing
Our reputation is built on quality, reliability, and compliance, making us the preferred partner for global pharmaceutical distributors.
Frequently Asked Questions
Do you offer Tenofovir, Emtricitabine and Efavirenz Tablets for bulk and contract manufacturing?
Yes. Kureasia Pharma provides bulk, contract, and 3rd party manufacturing of Tenofovir, Emtricitabine and Efavirenz Tablets under WHO-GMP standards with strict quality control and validated batch testing.
Can you export Tenofovir, Emtricitabine and Efavirenz Tablets to Nigeria, Iraq, Africa & Middle East?
Absolutely. We supply export-ready Tenofovir, Emtricitabine and Efavirenz Tablets with complete documentation, regulatory support, and proper packaging for seamless delivery to Nigeria, Iraq, African countries, and Middle Eastern markets.
What quality and compliance standards do you follow for this formulation?
Every batch of Tenofovir, Emtricitabine and Efavirenz Tablets is tested for potency, stability, dissolution, microbial safety, and uniformity under WHO-GMP certified production to meet international pharmacopoeial standards.
Who can source Tenofovir, Emtricitabine and Efavirenz Tablets from Kureasia Pharma?
We supply importers, wholesalers, government tenders, hospital procurement agencies, and pharmaceutical distributors requiring bulk supply, contract agreements, or 3rd party manufacturing of Tenofovir, Emtricitabine and Efavirenz Tablets.
Partner With Kureasia Pharma Today
Whether you need bulk supply, contract manufacturing, or 3rd party production, Kureasia Pharma is equipped to deliver Tenofovir, Emtricitabine and Efavirenz Tablets globally. Our services cover Nigeria, Iraq, Africa, and the Middle East, with full regulatory and export support.
Contact us today to secure high-quality antiretroviral medications for your healthcare or distribution network.
Office Info
+91 95577 45784
+91 93110 19560
011-40234824
sales@kureasiapharma.com
B- 255,Third Floor, Munshi Ram Gupta Marg, Naraina Industrial Area Phase 1, New Delhi 110028
Industrial Area, Plot Number-1, Khasra No. 882, 883k, Village-Salempur, Mehdood-II, Haridwar 249402, INDIA
Let’s Discuss Your Requirements
Your Trusted Pharma Partner—From Formulation to Fulfillment
Join hands with Kureasia Pharma’s advanced production line for tablets, syrups, ointments, and more.
Copyright © 2026 Kureasia Pharma | Developed by OTD